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Background: Abdominal aortic aneurysm (AAA) is considered a manifestation of 
atherosclerosis, however there are epidemiologic, biochemical, and structural differences 
between occlusive atherosclerosis and AAA. The pathogenesis of AAA involves several fac-
tors, ﬁ  rst of all destruction of collagen and elastin in the aortic wall. Classical risk factors may 
inﬂ  uence the evolution and development of AAA, though no consistent association has been 
found. Aims of the study were to evaluate associations between risk factors and to establish the 
prevalence of carotid, peripheral vascular and coronary atherosclerosis in patients with AAA.
Methods: We studied 98 patients with AAA (Group 1) awaiting surgery compared with high 
cardiovascular risk population having two or more risk factors (n = 82 Group 2). We evaluated 
traditional risk factors and we studied by eco-doppler and echocardiography the presence of 
carotid peripheral and coronaric atherosclerosis in two groups.
Results: We found a higher incidence of AAA in males (p   0.01). The prevalence of infrarenal 
AAA was signiﬁ  cantly higher than suprarenal AAA (81 vs 17 p   0.001). No differences in total 
cholesterol (199 ± 20 vs. 197 ± 25 mg/dl), low-density lipoprotein (142 ± 16 vs. 140 ± 18 mg/dl), 
triglycerides (138 ± 45 vs. 144 ± 56 mg/dl), glycemia (119 ± 15 vs. 122 ± 20 mg/dl), and 
ﬁ  brinogen (388 ± 154 vs. 362 ± 92 mg/dl) were found between groups. We demonstrated 
signiﬁ  cant differences for cigarette smoking (p   0.002), systolic and diastolic blood pres-
sure (150 ± 15 vs. 143 ± 14 mmHg and 88 ± 6 vs. 85 ± 7 mmHg, p   0.0001 and p   0.05, 
respectively) and high sensititivity C reactive protein (2.8 ± 1.3 vs. 1.3 ± 0.7 mg/dl, p   0.001). 
High-density lipoprotein (HDL) cholesterol levels were signiﬁ  cant greater in Group 1 than 
Group 2 (p   0.003). Subgroups of patients with AAA and luminal thrombus showed higher 
ﬁ  brinogen levels (564 ± 235 vs. 341 ± 83 mg/dl, p   0.001) and lower HDL than in controls 
(46.6 ± 6.5 vs. 52.1 ± 7.8 mg/dl, p   0.01). We did not ﬁ  nd any difference in body mass index, 
or prevalence of coronary and peripheral atherosclerosis between groups. Conversely, we found 
higher prevalence of carotid atherosclerosis in Group 2 (9% vs. 25%, p   0.004).
Conclusion: Our AAA patients had fewer and different risk factors respect to patients with 
atherosclerosis. Only elevated blood pressure, C reactive protein, and smoking showed a sig-
niﬁ  cant association with AAA. Atherosclerosis in other arterial districts did not differ respect 
to subjects with high cardiovascular risk. Our results conﬁ  rm the hypothesis that AAA and 
atherosclerosis are two different pathological entities with different risk proﬁ  les.
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Introduction
Abdominal aortic aneurysm (AAA) has high prevalence in the cardiovascular disease 
and it is considered a manifestation of atherosclerosis. This view has been increasingly 
questioned in recent years. Although many AAA are associated with conventional risk 
factors, a causal relation with atherosclerosis has not been conﬁ  rmed. Most patients Vascular Health and Risk Management 2008:4(4) 878
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with cardiovascular disease do not develop AAA, and many 
AAA patients do not have peripheral carotid or coronary 
disease (Reed et al 1992).
Though atherosclerosis plays some role in the pathogenesis 
of AAA, additional processes respect to occlusive atheroscle-
rosis are probably involved, as suggested by histological and 
macroscopic differences. In comparison to atherosclerosis, 
vascular tissue in AAA is characterized by high proteolytic 
activity and greater inﬁ  ltration of inﬂ  ammatory cells. Family 
histories of AAA indicate that genetic factors are also involved 
(Brophy et al 1991; Mac Sweeney et al 1994).
Several studies have shown that AAA and athero-
sclerosis have got risk factors such as age, hypertension, 
smoking, and hypercholesterolemia (Vardulaki et al 2000). 
Others reports revealed epidemiological differences among 
coronary and carotid disease and AAA (Alcorn et al 1996; 
Coggon et al 1996). In line with this, many authors did not 
found any association with common risk factors except 
for smoking (Blanchard et al 2000; Vardulaki et al 2000; 
Singh et al 2001). However, these studies are limited by 
the short duration of follow-up, small sample size, different 
inclusion criteria, and little information on risk factors, and 
epidemiology (Lilenfeld et al 1987). Identiﬁ  cation of risk 
indicators is important to improve stratiﬁ  cation, to prevent 
aortic dilation, and to select appropriate medical or surgical 
therapy (Alcorn et al 1996; Bengtsson et al 1996). The aims 
of this study were to investigate the prevalence of AAA 
in high cardiovascular risk patients, the prevalence of risk 
factors and AAA, the distribution of infrarenal/suprarenal 
AAA in patients awaiting surgical treatment. A further aim 
was to compare cardiovascular risk pattern between AAA 
population and asymptomatic age-matched subjects having 
two or more high cardiovascular risk factors.
Materials and methods
A case-control study was performed at Siena University Hos-
pital between June 2003 and December 2006. We recruited 
98 patients with AAA (group 1) and 82 control subjects 
(group 2). The two groups were matched for age, race, and 
sex. All patients underwent cardiologic examination with 
electrocardiogram, weight and height measurement, X-ray, 
and routine blood chemistry including glucose, low-density 
lipoprotein (LDL) and high-density lipoprotein (HDL) cho-
lesterol, liver and renal function parameters, electrolytes, 
ﬁ  brinogen, hemochrome, and high sensitivity C-reactive 
protein (hsCRP). They underwent ultrasonographic exami-
nation of the abdominal, peripheral, and carotid arterial 
segments. To assess coronary disease subjects underwent 
echocardiography stress examination with dipyridamol 
(Picano 2004) Patients with AAA also underwent computed 
tomography (CT) examination to assess intraluminal throm-
bosis and aortic transverse diameter.
Biochemical laboratory assessment
All blood samples were taken after a minimum 4-hour fast. 
Venous blood was taken in ethylenediaminetetraacetic acid 
(EDTA) tubes. The plasma samples were snap-frozen within 
1 hour to −20° C and stored at −80° C within a week. All 
EDTA plasma for analyses were thawed and analyzed at 
the same time. LDL and HDL cholesterol concentrations 
were measured by direct, homogeneous assays based on 
detergent treatment of the serum (N-geneous HDL-c and 
N-geneous LDL reagents, respectively, from Genzyme 
Corp, Cambridge, MA, USA). hsCRP was measured by 
a latex-enhanced immunoturbidimetry assay (Tina-quant 
CRP [Latex] HS, Roche Diagnostics GmbH, Mannheim, 
Germany). Plasma ﬁ  brinogen levels was measured by the 
Clauss modified method with coagulomether (Behring 
Diagnostics, Marburg, Germany).
Cardiovascular risk factors
Body mass index (BMI) was calculated as weight divided by 
the square of height (kg/m2). Blood pressure was recorded dur-
ing cardiological examination in a quiet room after ﬁ  ve minutes 
rest in sitting position; three measures were made at 2 minute 
intervals (oscillometric method, Colin Meter, Germany). 
Hypertension was deﬁ  ned as systolic blood pressure 140 
mmHg or higher and/or diastolic blood pressure 90 mmHg or 
higher in the absence of self-reported use of antihypertensive 
therapy, and treated hypertension was deﬁ  ned as self-reported 
physician-diagnosed hypertension under treatment.
Hyperlipidemia was deﬁ  ned as cholesterol total higher 
than 240 mg/dl; LDL cholesterol higher than 140 mg/dl, and 
HDL cholesterol lower than 35 mg/dl.
Diabetes mellitus was deﬁ  ned as nonfasting plasma 
glucose levels higher than 126 mg/dl or use of  oral 
antidiabetic drug or insulin.
Smoking history was deﬁ  ned as greater than or equal 
to 100 cigarettes/year. Patients were considered to have 
hypertension, hypercholesterolemia, or diabetes if they had 
been given these diagnoses by a physician or were treated 
for these conditions.
Examinations
Abdominal ultrasonographic examination of the abdominal 
aorta was performed by two blinded physicians. Subjects Vascular Health and Risk Management 2008:4(4) 879
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lay in supine position and/or in their left side if necessary. A 
3.5 MHz sector probe (5500 SONOS Hewlett-Packard) was 
used. The abdominal aorta was ﬁ  rst visualized in the longitu-
dinal plane from the diaphragm to the iliac bifurcation. The 
aorta was studied in the axial plane with scans perpendicular 
to the previous ones. Longitudinal and transverse aortic diam-
eter was measured at the renal arteries, 5 cm distally, and at 
the bifurcation. Transverse wall thickness and endoluminal 
diameter were measured. In the case of AAA with mural 
thrombus true and false lumen diameter were also measured. 
All AAA patients were also submitted to abdominal CT to 
evaluate vessel lumen and parietal thining.
Echocardiographic examination was performed under 
baseline conditions and during infusion of dipyridamol, 
atropine according to American Society of Echocardiogra-
phy criteria (Schiller et al 1989). Stress echocardiography 
was performed by dypiridamol and atropine infusion at 
standard doses with electrocardiogram (ECG) recording; it 
was stopped if clinical, echographic, or electrocardiographic 
alterations occurred. All scans were evaluated in apical, four 
and two chambers, and longitudinal and short parasternal 
views by two experienced physicians.
The vascular and carotid ultrasonographic examinations 
were performed using either an ATL HDI 3000 or 5000 (Phil-
ips Medical Systems, Monza, Italy). Information obtained 
from color-flow/B-mode imaging and Doppler spectral 
waveform analysis from the distal aorta to the pedal arteries 
was used to draw a schematic color-coded map of the arte-
rial tree. The arteries were scanned in cross and longitudinal 
sections using scanheads of 3–2, 5–2, 7–4, and 10–5 MHz 
extended operating frequency range. The arterial segments 
evaluated were classiﬁ  ed as normal or mildly diseased (less 
than 50% narrowing), signiﬁ  cantly stenosed (greater than 
50%), occluded, or not visualized. Focal stenosis was graded 
based on B-mode imaging of the plaque and residual lumen 
in cross section, whenever applicable, presence of color ﬂ  ow 
disturbances, and velocity spectral waveform analysis. A 
peak systolic velocity (PSV) ratio greater than 2 was used 
to tell hemodynamically signiﬁ  cant ( 50%) from hemo-
dynamically insigniﬁ  cant stenosis. Long arterial narrowing 
(residual lumen  50% of the actual artery diameter) in dif-
fusely diseased arterial segments was also observed based on 
B-mode/color-ﬂ  ow imaging. Presence of intraluminal echoes 
and absence of color ﬂ  ow conﬁ  rmed artery occlusion. Iliac 
disease was assessed by direct ultrasonographic visualization 
and by observation of common femoral artery (CFA) 
waveform abnormalities in the spectral window, number of 
phases, and acceleration time ( 140 ms considered abnormal). 
For the scanning protocol, the test starts with femoral arteries 
scanning and is followed by the popliteal artery examina-
tion. The popliteal artery is scanned both from the medial 
and posterior approaches. The tibioperoneal trunk, peroneal, 
and anterior tibial arteries are examined in lateral decubitus. 
The aorta, iliac, posterior tibial, dorsalis pedis, and common 
plantar arteries are scanned after returning the patient to the 
supine position.
B-mode real-time ultrasound was performed in blind, 
evaluating the arterial stenosis in the carotid arteries with 
a probe of 7.5–10.0 MHz. Patients were examined in the 
supine position and each carotid wall or segment was 
examined. Each scan of the common carotid artery began 
just above the clavicle, and the transducer was moved until 
the carotid bifurcation and along the internal carotid artery. 
Three segments were identiﬁ  ed and measured in antero and 
posterior planes on each side: the distal 1.0 cm of the common 
carotid proximal to the bifurcation, the bifurcation itself, 
and the proximal 1.0 cm of the internal carotid artery. At 
each of these sites we detected any possible plaque. Carotid 
lesions were considered pathological if they were higher than 
50% of the vascular lumen or have peak velocity more than 
100 cm/sec. Intra-observer coefﬁ  cience of variance was 5% 
and inter-observer coefﬁ  cience of variance was 10%.
Inclusion criteria
AAA subjects were enrolled if they had transverse aortic 
dilation  4.5 cm and no history of cardiovascular disease. 
All were elegible for surgery due to aneurysm dimensions. 
This group also underwent computed tomography. The con-
trol group consisted of age-matched subjects referred to the 
Cardiology Laboratory of our Department with at least two 
risk factors but without clinical evidence of atherosclerosis 
diseases such as coronary heart disease, peripheral arterial 
disease. Subjects gave written informed consent and the study 
was approved by the Ethical Committee.
Exclusion criteria
Patients with previous vascular or cardiac events such as 
myocardial infarction, angina, claudicatio intermittens 
or stroke, aortic dissection or dissecting aneurysm were 
excluded. Subjects with neoplastic, immunological, liver, 
or kidney disease were also excluded. Patients with Marfan 
syndrome were excluded.
Results
Of the 98 patients in group 1, 76 were males and 22 females. 
Of these patients, 81 had infrarenal and 17 suprarenal 
AAA (p   0.001). 45% had endoluminal thrombus. Mean Vascular Health and Risk Management 2008:4(4) 880
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transverse diameter of aneurysms was 5.4 cm (4.8 for 
suprarenal and 5.9 for infrarenal) (Table 1). Of the 82 patients 
in group 2, 50 were males and 32 females (mean age in both 
group 74 ± 8, range 62 to 87 years).
The frequency of peripheral vasculature disease was 
similar in the two groups: 15 (19%) controls and 19 (20%) 
AAA patients.
The incidence of coronary disease evaluated by stress-
echo test was similar in both groups: 17 (23%) in controls, 
25 (26%) in AAA patients (NS). Patients with AAA showed 
less evidence of carotid atherosclerosis than controls: Group 
1 9 patients (9%), 18 controls (25%), (p   0.004) (Figure 1). 
Two patients in the control group had recruited AAA (mean 
diameter infrarenal 4.5 cm).
No signiﬁ  cant differences in BMI was found, both groups 
showing high frequency of ﬁ  rst degree obesity (Controls 
28 ± 3.6, Group 1 29 ± 3.8 kg/m2). The percentage of patients 
with cholesterol over 200 mg/dl was 33% in Group 1 and 
35% in controls (199 ± 20 and 197 ± 25 mg/dl, respectively 
NS). Likewise no differences were found for LDL cholesterol 
(Group 1 142 ± 16 vs. Group 2 140 ± 18 mg/dl NS), or blood 
glucose (Group 1 119 ± 15 vs. Group 2 122 ± 20 mg/dl NS). 
Signiﬁ  cant differences regarding hsCPR were found: Group 1 
2.8 ± 1.3 vs. Group 2 1.3 ± 0.7 mg/dl (p   0.001).Triglycer-
ide levels were not signiﬁ  cantly different in the two groups 
(Group 1 138 ± 45 vs. Group 2 144 ± 56 mg/dl NS). HDL 
cholesterol levels were signiﬁ  cantly greater in Group 1 than 
in controls (Group 1 52.1 ± 7.8 vs. Group 2 47.5 ± 6.5 mg/dl, 
p   0.003). On the contrary HDL level was signiﬁ  cantly less 
in AAA subgroup associated with wall thrombosis than in 
AAA without thrombosis (46.6 ± 6.5 vs. 52.1 ± 7.8 mg/dl, 
p   0.01) (Figure 2).
Signiﬁ  cant differences in systolic and diastolic blood 
pressure were found: Group 1 150 ± 15 vs. Group 2 
143 ± 14 mmHg (p   0.001) and Group 1 88 ± 6 vs. Group 
2 85 ± 7 mmHg (p   0.05). When patients were divided 
into two groups according to blood pressure cut-off of 
140/90 mmHg, 42% of controls and 71% of AAA patients 
had hypertension (p   0.0006). Past or present cigarette 
smoking was more frequent in AAA patients: Group 1 
59(66%) Group 2 31 (40%) (p   0.002) (Table 2). 
Fibrinogen levels was similar in both groups (Group 1 
388 ± 154, Group 2 362 ± 92 mg/dl, NS). When Group 1 was 
divided into two subgroups, with wall thrombosis (n = 46) 
and without, the thrombosis subgroup demonstrated higher 
ﬁ  brinogen levels (564 ± 235 vs. 341 ± 83 mg/dl, p   0.0001) 
(Figure 3).
Discussion
Occlusive vascular disease and AAA are considered mani-
festations of the same atherosclerotic process, however there 
are many differences in pathophysiology and morphology 
between the two diseases (Louwrens et al 1993; Patel et al 
1995). Traditionally, atherosclerosis is characterized by 
increase in plaque volume due to growth of the lipid core into 
the vessel lumen and migration of smooth muscle cells and 
macrophages, leading to endothelial dysfunction, increase 
in intima-media thickness, and wall thickness. On the other 
hand, aneurysm involves dilation of all layers of the artery 
wall: parietal deterioration is due to loss of elastin and smooth 
muscle cells. Biochemical studies of possible genetic causes 
have focused on structural defects in aorta matrix proteins, 
overactive proteolysis and impaired homeostasis of collagen 
(Cannon and Read 1982; Brophy et al 1991; Cohen et al 
1992). Steinberg and colleagues (2000) recently demon-
strated different inﬂ  ammatory responses in the two diseases 
with elevated cytokine levels in AAA. There have been 
large prospective studies about the relationships between 
cardiovascular disease risk factors and AAA, and most of 
them are limited by small statistical samples, short follow-
up, different inclusion criteria, and different deﬁ  nitions of 
AAA (Lilienfeld et al 1987; Blanchard et al 2000; Singh et al 
2001). All these problems could explain the different results 
reported by observational studies. Several population-based 
studies have established male gender, age, smoking, and a 
family history of AAA as independent risk factors for AAA 
(Louwrens et al 1993; Blanchard et al 2000; Jamrozik et al 
2000; Singh et al 2001). Although several studies revealed a 
strong association between AAA and atherosclerotic diseases 
(Simoni et al 1995; Blanchard et al 2000; Jamrozik et al 2000; 
Singh et al 2001), reports on possible associations between 
AAA and established risk factors for atherosclerosis such as 
hypercholesterolemia and hypertension have shown different 
results (Patel et al 1995; Simoni et al 1995; Jamrozik et al 
Table 1 Clinical and structural characteristics of patients with 
abdominal aortic aneurysm (AAA) and controls
 Group  1  Group  2
Number of patients  98  82
Male/Females 76/22  50/32
Age 74  ± 8  74 ± 8
Infrarenal AAA  81  2
Suprarenal AAA  17 
Mean transverse diameter  5.4 (5.9/4.8)  4.5 ± 0.3
(infra/super-renal)
% of endo luminal thrombus  45% Vascular Health and Risk Management 2008:4(4) 881
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2000; Singh et al 2001). Histological and epidemiological 
differences between AAA and atherosclerosis have further 
challenged the traditional theory that AAA is a manifesta-
tion of atherosclerosis (Lilienfeld et al 1987; Louwrens et al 
1993; Satta et al 1998; Singh et al 2001).
Data in the literature regarding the relationship between 
AAA and cholesterol levels are contradictory. In a large 
screening study, the ADAM study (Lederle et al 2000), high 
cholesterol levels were independently associated with AAA 
in a multivariate analysis including atherosclerosis. Simoni 
and colleagues (1995) showed a relationship between lower 
HDL cholesterol levels and AAA, but no difference was 
observed in LDL cholesterol or total cholesterol levels. In the 
Tromso study, a highly signiﬁ  cant relation between low HDL 
cholesterol and the risk of AAA was found (Singh et al 2001). 
We did not show a signiﬁ  cant association with serum lipids 
(LDL cholesterol and triglycerides), which may be due to the 
high risk comparison group: indeed, we analyzed AAA in a 
late stage when alterations in serum lipids could not be directly 
involved in the pathogenesis (Lee et al 1997). Curiously, 
low HDL levels were signiﬁ  cantly associated to thrombotic 
aneurysms, probably due to elevated lipoprotein consumption 
and turnover. Our ﬁ  ndings appear in accordance with Simoni 
and colleagues (1995) and ADAM study data, which reveals 
an association with HDL cholesterol. Patients with AAA and 
parietal thrombus also had high ﬁ  brinogen levels in respect 
Figure 1 Prevalence of carotid disease (CAROTID), peripheral arterial disease (PAD), and coronary artery disease (CAD) in the two groups.
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Figure 2 HDL cholesterol difference in AAA with and without thrombus and in 
controls.
Abbreviations: AAA, abdominal aortic aneurysm; HDL, high-density lipoprotein.
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Figure 3 Different levels of ﬁ  brinogen in AAA with and without thrombus and in 
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to controls groups. Both ﬁ  ndings may explain at least in part 
the pathophysiological mechanism: ﬁ  brin binds to lipopro-
teins and sequesters more ﬁ  brinogen in the vascular intima, 
enhancing their accumulation. Fibrinogen is also an essential 
component of platelet aggregation, increasing plasma viscos-
ity, and it is correlated with ﬁ  brin levels in clots (Heinrich 
and Assmann 1995).Many studies found hypertension to be 
associated with AAA (Jamrozik et al 2000; Vardulaki et al 
2000). In line with this data, we found a correlation with both 
elevated diastolic and systolic blood pressure. The mechanism 
leading to the development of aortic enlargement is related to 
increased wall tension according to Laplace’s law. Hyperten-
sion increases wall stress, altering elastin and collagen, caus-
ing wall thickening, and precipitating aneurysm formation 
(Naydeck et al 1999; Rodin et al 2003).
Smoking has consistently been associated with AAA 
(Lee et al 1997; Jamrozik et al 2000; Lederle et al 2000; 
Törnwall et al 2001) and several studies have found a 
dose-response relationship suggesting a causal role for 
smoking in the etiology of AAA. Smoking per se promotes 
atherosclerosis, and may also upset protease/antiprotease 
balance and occlude the vasa vasorum in this tract where 
the vascularization is reduced with respect to the district of 
the thoracic aorta (Cannon and Read 1982; Louwrens et al 
1993; Lee et al 1997; Lederle et al 2000). Lawlor and col-
leagues (2008) emphasized the role of smoking as a major 
risk factor for cardiovascular diseases in populations with 
low cholesterol levels.
HsCRP has recently emerged as a strong independent 
risk factor for atherosclerosis and atherosclerosis-related 
complications in apparently healthy individuals and patients 
with cardiovascular disease (Ridker et al 1997; Lagrand et al 
1900). Powell and colleagues (1987) showed that, among 
patients undergoing elective aortic reconstruction, serum 
hsCRP was elevated in AAA patients compared with patients 
with obstructive disease. The elevation of hsCRP was equally 
pronounced in small and large AAA, indicating an inﬂ  am-
matory process in the early pathophysiologic phase of AAA. 
These ﬁ  ndings corroborate the notion that CRP up-regulation 
is a reaction to several types of tissue injury. Macrophages 
and smooth muscle cells might be the producers of ‘vascular’ 
CRP (Yasojima et al 2001).
No differences were found in carotid and peripheral athero-
sclerosis between groups: carotid disease seemed less frequent 
in the AAA group compared with the high risk group.
A similar study reveals that mean carotid intima-media 
thickness in AAA patients was similar to healthy subjects 
and signiﬁ  cantly lower than patients affected to peripheral 
atherosclerosis. The ﬁ  ndings support the notion that the 
formation of AAA is not fully atherosclerosis-dependent 
(Cheuk et al 2007).
These data appear consistent with those of SMART, which 
did not show a strict correlation between signiﬁ  cant carotid 
stenosis in a large population study (Simons et al 1999).
AAA patients had fewer and different risk factors respect 
to patients with atherosclerosis. Only elevated blood pressure 
and smoking showed a signiﬁ  cant correlation with AAA. 
Atherosclerosis in other districts appears similar respect to 
high cardiovascular population.
Conclusions
In conclusion, the present study demonstrates that AAA 
and atherosclerosis differ in certain pathophysiological 
aspects and risk factors. However risk factors such as 
hypertension and cigarette smoking and hsCRP, could 
negatively promote further dilation. Cardiac, peripheral, 
and carotid vascular ultrasonography study demonstrated 
different risk proﬁ  les in the two diseases. Further studies 
into other potential risk factors, such as inflammation, 
autoimmunity, and genetics, may be warranted.
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